MARATTO

article · Journal of the Egyptian Society of Parasitology

INTESTINAL PARASITIC INFECTIONS IN PATIENTS WITH IRRITABLE BOWEL SYNDROME IN SOHAG, EGYPT

20241 citationOpen accessSohag University

Abstract

Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder of uncertain etiology.Several studies have proposed the possible role of intestinal parasites in the pathogenesis of IBS.The study evaluated the prevalence of intestinal parasitic infections (IPIs) in patients with IBS incomparison with healthy control group in Sohag. Case-control study was conducted on 100 patientswith IBS and 100 healthy controls. The IBS patients were selected based on the Rome IVcriteria. All participants filled a structured questionnaire that covered demographic and clinicaldata. Stool samples were collected and examined by direct wet mounts, formalin ethyl acetateconcentration technique and modified Kinyoun's acid-fast stain and in vitro culture for Blastocystisspp. IBS patients were 30% males and 70% females (32.82±12.89) years and controls were35% male and 65% females (29.4±10.41) years. Prevalence of IPIs in IBS patients (66%) wassignificantly higher than in controls (30%) with (P<0.0001) and the most common parasites inIBS patients were Blastocystis hominis (46%) and Cryptosporidium spp. (20%) with significantdifference between groups (p<0.001, P<0.0001) respectively. The infection rate was significantlyassociated with residence (P< 0.027), but neither associated with sex (P< 0.4) nor age (P< 0.123)among IBS patients. The study data support a possible link between parasitic infections and IBS.

Research topics

  • Parasites and Host Interactions

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/jesp.2024.373528

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.